SAN DIEGO, June 6 /PRNewswire-FirstCall/ -- Favrille, Inc. , a biopharmaceutical company developing patient-specific immunotherapies for the treatment of cancer, today announced that it will present at two upcoming investor conferences.
(Logo: http://www.newscom.com/cgi-bin/prnh/20031013/LAM095LOGO)
John P. Longenecker, Ph.D., President and Chief Executive Officer of Favrille, will present at the Pacific Growth Equities Life Sciences Growth Conference at 10:30 a.m. Pacific time on Monday, June 12, 2006. The conference will be held at the InterContinental Mark Hopkins Hotel in San Francisco.
Dan Gold, Ph.D., Chief Scientific Officer of Favrille, will present at the Needham Biotechnology & Medical Technology Conference at 2:00 p.m. Eastern time on Wednesday, June 14, 2006. The conference will be held at the New York Palace Hotel in New York City.
Live webcasts of both presentations can be accessed at www.favrille.com. Replays will be available approximately one hour after each presentation and archived for one month.
About Favrille, Inc.
Favrille, Inc. is a biopharmaceutical company focused on the research, development and commercialization of targeted immunotherapies for the treatment of cancer and other diseases of the immune system. The Company’s lead product candidate, FavId, is based upon unique genetic information extracted from a patient’s tumor. FavId is currently under investigation in a pivotal Phase 3 clinical trial for patients with follicular B-cell NHL and Phase 2 clinical trials in other B-cell NHL indications. The Company is developing additional applications based on its immunotherapy expertise and proprietary cost-effective manufacturing technology, including a second product candidate, FAV-201, for the treatment of T-cell lymphoma.
Company Contact: Pete De Spain Associate Director, Investor Relations & Corporate Communications Favrille, Inc. (858) 526-2426 pdespain@favrille.com
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20031013/LAM095LOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comFavrille, Inc.
CONTACT: Pete De Spain, Associate Director, Investor Relations & CorporateCommunications of Favrille, Inc., +1-858-526-2426, pdespain@favrille.com
Web site: http://www.favrille.com//
